Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRINTO JDM Trial
NCT00323960Phase 3Completed
- Sponsor
- Istituto Giannina Gaslini
- Start
- May 2006
- Primary completion
- May 2011
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate, cyclosporine in juvenile dermatomyositis (JDM), sponsored by Istituto Giannina Gaslini. Started May 2006; status: completed.
02
Drugs
methotrexatecyclosporine
03
Conditions
juvenile dermatomyositis (JDM)
Beyond the preview
Go deeper on NCT00323960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323960.